Real-time enrollment status for this myelodysplastic syndromes clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 8:20 PM UTC
| NCT Number | NCT06303193 |
| Recruiting Status | Recruiting |
| Condition | Myelodysplastic Syndromes |
| Phase | PHASE1 |
| Target Enrollment | 160 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | July 16, 2026 (Yesterday) |
As of July 17, 2026: Clinical trial NCT06303193 is currently recruiting participants. This phase1 study for myelodysplastic syndromes is actively seeking new participants at 1 location across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06303193 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06303193 was last updated Yesterday (July 16, 2026). HelloStudys verifies this status automatically.